Clinical Trials Browser

Rectal Neoplasms × Immune Checkpoint Inhibitors × Clear all

NCT06647680 2026-03-06

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）

Phase 2 Recruiting

Gastrointestinal

Pathologic Complete Response, Rectal Neoplasms

NCT06710847 2026-02-02

SYLVER

Phase 1/2 Active not recruiting

GastrointestinalGynecologic

Turcot syndrome, Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT06958432 2025-08-07

Node-Sparing Short-Course Radiotherapy Sequential Chemotherapy and PD-1 Inhibitor for Mid/Low pMMR/MSS Rectal Cancer (MODIFI-RC-II)

Phase 2/3 Recruiting

Gastrointestinal

Rectal Neoplasms

NCT06900686 2025-03-28

Clinical Application of PD-1 Inhibitor in Colorectal Cancer for Improving Survival

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colonic Neoplasms, Rectal Neoplasms

NCT05450029 2023-09-26

SILAR

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms

NCT05507112 2022-09-21

TIMENT-R

Phase 2 Not yet recruiting

Gastrointestinal

Rectal Neoplasms

NCT05484024 2022-08-02

Short-course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer

Phase 2/3 Not yet recruiting

Gastrointestinal

Rectal Neoplasms